In this study we correlated findings of brain MRI with intelligence in a group of 28 children with neurofibromatosis type 1.
In this study we correlated findings of brain MRI with intelligence in a group of 28 children with neurofibromatosis type 1. 54-148), with a mean verbal IQ of 95-7 and a mean performance IQ of 84 1 (paired t test, P = 2 x 1O-5). The mean age of the children was 9 years and 4 months. Eight children (four boys and four girls) were found with neurological diseases (two had epilepsy, two hydrocephalus, one a brain stem glioma with hydrocephalus and epilepsy, one an interhemispheric frontal tumour, one a congenital hemiparesis, and one had received irradiation because of bilateral and chiasmatic optic pathway glioma). As expected these eight children scored significantly lower on IQ tests than the other 20 children without neurological disease (table  1) .
Materials and methods
Brain MRI was scored for the presence and specific location of enhanced T2 weighted foci. In 18 of 28 children hyperintense T2 weighted spots were seen. These 18 children had a mean FSIQ comparable with the 10 children without spots (table 1) . The eight children with neurological diseases all showed the typical T2 weighted spots, and only 10 of the 20 children without any evidence of neurological disease showed them (P = 0-025; Fisher's exact test). In the group of children without neurological disease the 10 children with increased T2 weighted signals showed a higher mean FSIQ than the 10 children without (table 1) .
In this group of 28 children ANCOVA with age and the presence of neurological abnormalities as covariates, showed no significant relation between the number of T2 weighted foci in the brain and FSIQ (table 2) . Similarly, ANCOVA with the same covariates showed no relation between a specific location of T2 weighted hyperintensities and FSIQ (table 2). ANCOVA was not performed for temporal lobe, occipital lobe, parietal lobe, and vermis cerebelli, as the number of patients with enhanced T2 weighted foci in these regions of interest was one or zero.
Discussion
In the present study we could not find a relation between the presence or absence of T2 weighted hyperintens foci in the brain and scores on the Wechsler scales of intelligence. We identified a group of eight patients with neurofibromatosis type 1 who had other neurological disease and a significantly lower FSIQ. These eight children all had T2 weighted hyperintensities in their brains. The presence of neurological abnormalities in the eight children is likely related to neurofibromatosis type 1, although it is possible that some are coincidental. The 20 children without other neurological disease had a near normal FSIQ (95s1), and T2 weighted enhanced foci in the brain were present in 50% (10/20 with neurofibromatosis type 1 showed T2 weighted hyperintensities, which is higher than in any other reported study. North et al'5 studied 40 children without major neurological problems or frank mental retardation and found a bimodal distribution of FSIQ. Those with T2 weighted hyperintensities in the brain had a significantly lower total IQ than those without. In this study there was no correlation of FSIQ with the number or location of T2 weighted hyperintensities. The previous studies all differed in design (age groups, socioeconomic classes, sibling comparison) and they comprised relatively few subjects. These may be explanations for the different conclusions. Another explanation for these contradicting results may be that two or more different kinds of enhanced T2 weighted foci exist, those representing some kind of brain abnormality, and those not representing brain alterations. The eight children with other neurological disease in this study all showed T2 weighted hyperintense foci, and these foci might be different from those in the group without other neurological disease. Moreover, it is known that some T2 weighted hyperintensities in the brains of patients with neurofibromatosis type 1 disappear with time and it is possible to find them only at a certain age.'8 In the different studies the different relative proportion of these possibly different kinds of T2 weighted hyperintensities and the different ages when MRI was carried out might explain the opposite conclusions.
A larger set of patients with neurofibromatosis type 1 should be tested in a multicentre study to gain more insight into the possible association of cognitive problems in neurofibromatosis type 1 and T2 weighted enhanced foci in the brain. In this study investigators should use a standard protocol for patient selection, timing of MRI, and reporting of MRI abnormalities. In the mean time there is no good reason to suspect a mental problem when enhanced T2 weighted foci are found in the brain of a child with neurofibromatosis type 1 without other neurological disease.
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